Navigation Links
Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
Date:11/20/2013

essment of the following:

•What are the precise rights granted or optioned?•What is actually granted by the agreement to the partner company?•What exclusivity is granted?•What is the payment structure for the deal?•How aresalesand payments audited?•What is the deal term?•How are the key terms of the agreement defined?•How are IPRs handled and owned?•Who is responsible for commercialization?•Who is responsible for development, supply, and manufacture?•How is confidentiality and publication managed?•How are disputes to be resolved?•Under what conditions can the deal be terminated?•What happens when there is a change of ownership?•What sublicensing and subcontracting provisions have been agreed?•Which boilerplate clauses does the company insist upon?•Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Executive SummaryChapter 1 – IntroductionChapter 2 – Why do company's partner discovery, preclinical and clinical stage compounds?2.1. Introduction

2.2. The role of discovery, preclinical and clinical stage partnering

2.2.1. In-licensing at clinical stage

2.2.2. Out-licensing at discovery stage

2.2.3. Out-licensing at clinical stage

2.3. Difference between discovery, preclinical and clinical stage deals

2.4. Reasons for entering into discovery, preclinical and clinical stage partnering deals

2.4.1. Licensors reasons for entering discovery, preclinical and clinical stage deals

2.4.2. Licensees reasons for entering discovery, preclinical and clinical stage deals

2.5. The future of discovery, preclinical and clinical stage partnering deals




Chapter 3 – Discovery, preclinical and clinical stage deal strategies and structure

3.1. Introd
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
2. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
3. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
4. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
5. Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome
6. Positive Preclinical Profile of RG-101, a GalNAc-conjugated anti-miR Targeting microRNA-122, Supports Clinical Development for the Treatment of HCV
7. Data Presented For ENMD-2076 In Preclinical Models Of Triple-Negative Breast Cancer
8. MicroConstants Expands Biomarker Testing and Analysis Services for Preclinical and Clinical Diagnostic Research
9. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
10. Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
11. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... -- Boston Children,s Hospital,s Global Pediatric Summit + Awards, ... "Innovation Tank" – a forum designed to give pediatric ... or product solution to a panel of acclaimed judges ... accelerate the innovation and bring it to market. ... 31, will be moderated by Daymond John ...
(Date:7/24/2014)... 24, 2014  Bruin Biometrics (BBI), a pioneer ... after two weeks of clinical briefings to over ... it gained substantial concurrence on both the clinical ... utility of BBI,s SEM Scanner. ... the respondents drawn from the European Wound Management ...
(Date:7/24/2014)... N.J. , July 24, 2014  Bayer ... III trial that evaluated a 15% foam formulation ... topical treatment of inflammatory papules and pustules of ... treatment option to complement the currently available AzA ... causing inflammatory lesions (papules and pustules) as well ...
Breaking Medicine Technology:Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea 2Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea 3
... The Leukemia & Lymphoma,Society has awarded a $550,000 ... Wilmot Cancer Center at the University of Rochester Medical,Center. ... funding the first two years of the five-year program., ... will support,Dr. Friedberg,s work on a new targeted treatment ...
... Assay Submitted for FDA Clearance, SAN DIEGO, July ... and Company) (NYSE: BDX ), announced today the ... the rapid diagnosis,of patients with Clostridium difficile infection (CDI). ... simplicity and speed in one test,procedure. BD has also ...
Cached Medicine Technology:University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3
(Date:7/24/2014)... 2014 Indianapolis* VxP Pharma Services ... offering to include process development and commercial ... dosage forms offered by VxP now include:, ... Liquids ,     Sterile Liquids and Sterile ...     Topicals ,     Transdermal Patches , ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Dr. Peter ... Israel Deaconess Medical Center in Boston, is the new ... Dr. Oettgen brings his considerable experience in the field ... Health . , Dr. Oettgen received his medical ... and completed his residency at Tufts New England Medical ...
(Date:7/24/2014)... Texas (PRWEB) July 24, 2014 ... provides key market data on the North America ... millions of US dollars, and volume (in units) ... market categories Spinal Fusion, Vertebral Compression Fracture Repair ... Companies in North America Spinal Surgery Market:, ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 The European air ... billion in 2014, and is expected to register a CAGR ... France, Germany, Russia, and turkey are the major spenders in ... include medium extended air defense program and multinational (MEADS) program, ... , Browse through the TOC of the Europe air and ...
(Date:7/24/2014)... cancer involves exposing the patient or their tumor more ... X-rays. The radiation damages the cancer cells irreparably. Unfortunately, ... the skin over the site of the tumor, which ... and even skin cancer. As such finding ways to ... in the International Journal of Low Radiation, Faruck Lukmanul ...
Breaking Medicine News(10 mins):Health News:VxP Pharma Expands Commercial Service Offering 2Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 2Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 3Health News:Spinal Surgery Market in North America Forecast to 2020 New Report Available at ReportsnReports.com 2Health News:Spinal Surgery Market in North America Forecast to 2020 New Report Available at ReportsnReports.com 3Health News:Spinal Surgery Market in North America Forecast to 2020 New Report Available at ReportsnReports.com 4Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 2Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 3Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 4Health News:Natural products from plants protect skin during cancer radiotherapy 2
... , , , EAST HARTFORD, Conn., Aug. 6 ... Thursday morning August 6 due to a denial of service attack. , , ... , - Why are Web 2.0 sites like Twitter targets for ... brain than a simple website. Its users are within the brain and its neurons, ...
... , , MOUNTAIN VIEW, Calif., Aug. 6 ... will release its second quarter 2009 financial results after the market closes ... with the release, the Company will host a conference call with the ... Thursday, August 13, 2009 to discuss the results ...
... problems , THURSDAY, Aug. 6 (HealthDay News) -- Rooks aren,t birdbrains, ... the corvid, or crow, family can use stones to raise the ... within reach of their beak. , All four rooks used in ... exact number of stones needed to raise the water level to ...
... , National Psoriasis Foundation data show ... , , PORTLAND, Ore., Aug. 6 Emerging research ... medical conditions including heart disease, diabetes and obesity. According to a new ... two-thirds report having at least one other critical health problem , ...
... NEW YORK, Aug. 6 Care to Care, a ... that is has been awarded Full Accreditation in Health Utilization ... care accrediting organization. , , URAC ... care management through processes of accreditation and education. URAC ...
... , , WASHINGTON, Aug. ... non-profit organization of nearly 60 employer-based health care coalitions, representing ... dependents across the United States, submitted letters to the White ... as a critical strategy for health reform. NBCH sent correspondence ...
Cached Medicine News:Health News:Integralis Expert Resource Available to Discuss Twitter Denial of Service Attack and Web 2.0 Security 2Health News:Rooks Show Intelligence in Catching the Worm 2Health News:Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions 2Health News:Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions 3Health News:Care to Care Receives Full URAC Health Utilization Management Accreditation 2Health News:Care to Care Receives Full URAC Health Utilization Management Accreditation 3Health News:NBCH Calls for Cost Containment and System Transformation in Health Care Reform Legislation 2Health News:NBCH Calls for Cost Containment and System Transformation in Health Care Reform Legislation 3
Ideal for use with thinner casting materials such as polyester or fiberglass. Conforms to any casting material....
This lightweight cast boot features a sturdy canvas upper. The three layer EVA rocker outsole provides excellent shock absorption....
... assay for the qualitative and ... to Gliadin in human serum. ... be used as an aid ... disorders, mainly Coeliac Disease. This ...
... Myeloperoxidase IgG ELISA test system is intended ... IgG-class antibody to myeloperoxidase in human serum. ... used as an aid in the diagnosis ... elevated levels of anti-neutrophil cytoplasmic antibodies (ANCA). ...
Medicine Products: